The Solidarity Supply Index (SSI) — A Clinical Tool for Measuring Ethical Impact in Underserved Communities

The Solidarity Supply Index (SSI) represents a new class of humanitarian metric — one that integrates clinical relevance, ethical logistics, and structural determinants of health into a single, reproducible score. Developed by the Pan‑American Medical Association (PAMA), the SSI quantifies whether medical aid is not only delivered, but delivered ethically, transparently, and in alignment with the real clinical needs of underserved communities.

In a global landscape where the United States discards millions of tons of unused medical supplies annually — much of it sterile, viable, and clinically valuable — the SSI provides a scientific framework for transforming waste into life‑saving resources. WHO and PAHO data show that up to 40% of essential medicines in low‑resource countries experience stockouts, while JAMA estimates that U.S. healthcare waste exceeds $760 billion each year. The SSI bridges this gap by measuring how effectively surplus materials are recovered, validated, and delivered to health systems in crisis.

The 2026 SSI score of 8.7, though still classified as High‑Impact, reflects the growing influence of political determinants of health. Sanctions, fuel shortages, and transport restrictions in Cuba have intensified scarcity and reduced last‑mile deliverability — demonstrating that even ethically optimized humanitarian systems remain vulnerable to geopolitical forces. This decline does not signal diminished performance; rather, it reveals the ethical integrity of the SSI itself: a willingness to measure impact honestly, even when structural violence limits what humanitarian actors can achieve.

As global health systems confront rising instability, the SSI offers clinicians, policymakers, and humanitarian organizations a rigorous, data‑driven tool for evaluating the true reach of medical solidarity. It transforms humanitarian aid from an act of goodwill into a measurable, accountable, and clinically meaningful intervention.

Uriel Ramirez M.D.
I am Dr. Uriel Ramirez, a proud graduate of the Latin American School of Medicine (LASM) in Havana, Cuba, with a deep commitment to Anesthesiology and a passion for strengthening health infrastructure, systems, and logistics. My work is driven by a dedication to advancing equitable care and building sustainable models that leave a lasting impact on the field of medicine.
Sign up to read this post
Join Now
Previous
Previous

Spotlight: Dr. Renee Quarterman, MD — A Physician Who Shows What Solidarity Looks Like (Copy)

Next
Next

A Generation at Risk: How Cuba’s Food Crisis Is Breeding a Nutrition Epidemic